retatrutide phase 2 trial obesity nejm 2023

retatrutide phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Original Article: Triple–Hormone-Receptor Agonist Retatrutide

Name: retatrutide phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Original Article: Triple–Hormone-Receptor Agonist Retatrutide
Brand: www.rasophiles.fr
SKU: 45242163203
Price: 29.29 USD
Availability: InStock
Rating: 4.2736 (5 reviews)

SKU: 45242163203

4.3

EUR29.29 EUR77.29

Pay in 4 interest-free payments of $7.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 5 - Oct 10

Description

Adverse effects observed in clinical trials include: Gastrointestinal effects: nausea, vomiting, diarrhoea, and constipation particularly during dose escalation

Researchers seeking to evaluate its molecular binding profiles, stability, and structure can review its cataloged entries in the PubChem Compound Database or explore its registered active clinical trials listed on the ClinicalTrials.gov Database